BR112020020403A8 - metalo-liotironina - Google Patents
metalo-liotironinaInfo
- Publication number
- BR112020020403A8 BR112020020403A8 BR112020020403A BR112020020403A BR112020020403A8 BR 112020020403 A8 BR112020020403 A8 BR 112020020403A8 BR 112020020403 A BR112020020403 A BR 112020020403A BR 112020020403 A BR112020020403 A BR 112020020403A BR 112020020403 A8 BR112020020403 A8 BR 112020020403A8
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- liotironina
- metallo
- lyothyronine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862652705P | 2018-04-04 | 2018-04-04 | |
| US62/652,705 | 2018-04-04 | ||
| PCT/US2019/025725 WO2019195513A1 (en) | 2018-04-04 | 2019-04-04 | Metallo-liothyronine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112020020403A2 BR112020020403A2 (pt) | 2021-03-23 |
| BR112020020403A8 true BR112020020403A8 (pt) | 2021-04-13 |
Family
ID=68101148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020020403A BR112020020403A8 (pt) | 2018-04-04 | 2019-04-04 | metalo-liotironina |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11712426B2 (https=) |
| EP (1) | EP3773733B1 (https=) |
| JP (1) | JP7535993B2 (https=) |
| KR (1) | KR20200143701A (https=) |
| CN (1) | CN112218661A (https=) |
| AU (1) | AU2019247217A1 (https=) |
| BR (1) | BR112020020403A8 (https=) |
| CA (1) | CA3096199A1 (https=) |
| WO (1) | WO2019195513A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019195513A1 (en) * | 2018-04-04 | 2019-10-10 | Price John D | Metallo-liothyronine |
| JP2022030705A (ja) * | 2020-08-07 | 2022-02-18 | 日本曹達株式会社 | チアベンダゾール含有配位高分子 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1298613B1 (it) | 1998-03-10 | 2000-01-12 | Bracco Spa | Chelati complessi di manganese ad alta relassivita' in siero |
| WO2011101710A1 (en) * | 2010-02-16 | 2011-08-25 | Wockhardt Research Centre | Efflux pump inhibitors |
| JP2003261683A (ja) | 2002-03-06 | 2003-09-19 | Nof Corp | 中性（ベンゼン−１，２，４，５−テトラチオラート）金属錯体ポリマー、その製造方法および用途 |
| US7799937B2 (en) | 2004-10-25 | 2010-09-21 | Synthonics, Inc. | Metal coordinated compositions |
| US20060141054A1 (en) | 2004-10-25 | 2006-06-29 | Thomas Piccariello | Metal coordinated compositions |
| AU2013205471B2 (en) | 2005-10-24 | 2016-02-11 | Synthonics, Inc. | Metal coordinated compositions |
| JP5162758B2 (ja) | 2006-03-02 | 2013-03-13 | 大学共同利用機関法人自然科学研究機構 | マイクロチャンネルリアクター |
| US10150792B2 (en) * | 2010-11-08 | 2018-12-11 | Synthonics, Inc. | Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients |
| WO2015167010A1 (ja) | 2014-05-02 | 2015-11-05 | 国立研究開発法人物質・材料研究機構 | 有機／ヘテロ金属ハイブリットポリマー、その製造方法、有機／ヘテロ金属ハイブリットポリマーの膜、有機／マルチ金属ハイブリットポリマー、その製造方法、及び有機／マルチ金属ハイブリットポリマーの膜 |
| US9999626B2 (en) * | 2014-06-18 | 2018-06-19 | Thetis Pharmaceuticals Llc | Mineral amino-acid complexes of active agents |
| JP6838268B2 (ja) | 2015-10-21 | 2021-03-03 | コニカミノルタ株式会社 | 光変換材料、光変換フィルム、及び発光素子 |
| WO2019195513A1 (en) * | 2018-04-04 | 2019-10-10 | Price John D | Metallo-liothyronine |
-
2019
- 2019-04-04 WO PCT/US2019/025725 patent/WO2019195513A1/en not_active Ceased
- 2019-04-04 AU AU2019247217A patent/AU2019247217A1/en not_active Abandoned
- 2019-04-04 JP JP2021503706A patent/JP7535993B2/ja active Active
- 2019-04-04 US US17/045,234 patent/US11712426B2/en active Active
- 2019-04-04 CN CN201980028465.9A patent/CN112218661A/zh active Pending
- 2019-04-04 BR BR112020020403A patent/BR112020020403A8/pt unknown
- 2019-04-04 CA CA3096199A patent/CA3096199A1/en active Pending
- 2019-04-04 KR KR1020207031803A patent/KR20200143701A/ko not_active Ceased
- 2019-04-04 EP EP19781565.7A patent/EP3773733B1/en active Active
-
2023
- 2023-07-31 US US18/362,813 patent/US20230381126A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021521268A (ja) | 2021-08-26 |
| BR112020020403A2 (pt) | 2021-03-23 |
| CN112218661A (zh) | 2021-01-12 |
| US20230381126A1 (en) | 2023-11-30 |
| JP7535993B2 (ja) | 2024-08-19 |
| EP3773733A1 (en) | 2021-02-17 |
| WO2019195513A1 (en) | 2019-10-10 |
| EP3773733A4 (en) | 2022-05-25 |
| CA3096199A1 (en) | 2019-10-10 |
| EP3773733B1 (en) | 2025-11-12 |
| EP3773733C0 (en) | 2025-11-12 |
| AU2019247217A1 (en) | 2020-11-26 |
| US20210046032A1 (en) | 2021-02-18 |
| KR20200143701A (ko) | 2020-12-24 |
| US11712426B2 (en) | 2023-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019502851A1 (en) | New azaquinoline derivatives | |
| PH12020500257A1 (en) | Quinoline derivatives for treating infections with helminths | |
| JOP20220131A1 (ar) | مركبات أمينو كينولون تحمل بدائل تستخدم كمثبطات لـ dgkalpha من أجل تنشيط المناعة | |
| MX389697B (es) | Nuevos derivados de pirazolopirimidina. | |
| GEP20237506B (en) | Pcsk9 antagonist compounds | |
| GEAP202416095A (en) | Substituted aminothiazoles as dgkzeta inhibitors for immune activation | |
| MX2023005160A (es) | Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma. | |
| DK3577110T3 (da) | 8-oxetan-3-yl-3,8-diazabicyclo[3.2.1]octan-3-yl-substituerede forbindelser som hiv-inhibitorer | |
| MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
| PH12019501846A1 (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | |
| GEAP202215479A (en) | Magl inhibitors | |
| MX380753B (es) | Lactamas bicíclicas y métodos de uso de las mismas. | |
| MX2022015257A (es) | Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas. | |
| PH12020551891A1 (en) | New quinoline derivatives | |
| CL2021002309A1 (es) | Compuestos útiles en la terapia del vih | |
| MX2019014041A (es) | Inhibidores pirazolicos de magl. | |
| PH12020500134A1 (en) | Dihydrooxadiazinones | |
| WO2018107155A8 (en) | SUL-RICH AND N-H-FREE PERHYDRIDOPOLYSILZANE COMPOSITIONS, SYNTHESIS AND USES THEREOF | |
| GEAP202215303A (en) | Chromane monobactam compounds for the treatment of bacterial infections | |
| MA46490A1 (fr) | Dérivés de nucléosides 4'- fluoro-2' - méthyle substitués | |
| MX2022006817A (es) | Formulaciones/composiciones que comprenden un inhibidor de btk. | |
| MX2022006768A (es) | Formulaciones/composiciones que comprenden un inhibidor de btk. | |
| MX2019012803A (es) | Nuevos derivados de pirazol biciclicos. | |
| PH12020500105A1 (en) | Bicyclic ketone compounds and methods of use thereof | |
| JOP20190262B1 (ar) | مثبطات بيرازول magl |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25B | Requested transfer of rights rejected |
Owner name: SYNTHONICS, INC. (US) Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870200148761 DE 25/11/2020, EM VIRTUDE DA SOLICITACAO JA TER SIDO ATENDIDA PELA PUBLICACAO DO DESPACHO 1.3.1 DA RPI2623 DE 13/04/2021. |
|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |